This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer (PaFLO)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2012 by P. C. Thuss-Patience, Charite University, Berlin, Germany.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
P. C. Thuss-Patience, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01503372
First received: December 22, 2011
Last updated: January 10, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)